BIO – COMPATIBLE, DEGRADABLE, RESORBABLE
OXIDIZED CELLULOSE has been used in the health sector for many years as a local haemostat. It is known as a biodegradable, bioresorbable and biocompatible 1 polymer with no adverse reaction to the body. Thanks to its antimicrobial effect against a wide range of pathogenic microorganisms and healing effects, oxidized cellulose brings significant benefits to many medical applications.
WIDE RANGE OF USES
OKCEL® is a non-regenerated oxidized cellulose haemostat designed to control internal capillary, venous and minor arteriolar bleeding during a wide range of surgical procedures, including minimally invasive procedures, in which conventional measures such as sutures or ligatures are ineffective or unfeasible. 2
OKCEL® is perfectly accepted by organism and usually absorbed within 14 days 3, 4 with practically no tissue reaction, depending on the quantity of product used, the level of blood saturation and the character of tissue.
Haemostasis is achieved approximately within 1.5 minutes 3, 4. Fast bioresorbability / biodegradability and high haemostatic capacity of OKCEL® is supported with its outstanding absorbency and large surface area. 5
BACTERICIDAL AND BACTERIOSTATIC PROPERTIES
OKCEL® products show a clear antimicrobial effect on large spectrum of pathogens 6 (including antibiotic resistant bacteria MRSA, PRSP, VRE, MRSE) and thus help with the tissue regeneration.
EASY HANDLING AND POSITIONING
OKCEL® is a haemostatic material with excellent properties such as easy handling, possibility of (re)positioning and shape stability. 5
100% NATURAL RAW MATERIAL
OKCEL® is produced by selective oxidation of extra-long staple cotton of the premium quality.
TRADITIONAL EUROPEAN PRODUCER
OKCEL® is manufactured by well-established European company with 100 years of history.
1. For OKCEL ® products proven by biocompatibility testing in accordance with EN ISO 10993. Data on file: 18640-033.
2. Based on OKCEL® instructions for use. Data on file: 18640-033.
3.Jindřich Lahovský, MD. Evaluation of efficacy and safety of medical devices series OKCEL®. Study Report Ref. No AP-SY-1501. Data on file: 18640 – 033.
4. Jindřich Lahovský, MD. Evaluation of efficacy and safety of the medical device OKCEL® S. Study Report Ref. No AP-SY-1701. Data on file: 18640 – 033.
5. Jindřich Lahovský, MD. Závěrečná zpráva laboratorního vyhodnocení vlastností hemostatik na bázi oxidované regenerované a neregenerované celulózy. Study Report Ref. No. AP-SY-1901. Data on file: 18640 – 034.
6. Ing. Iveta Brožková, Ph. D. Department of Biological and Biochemical Sciences at the Faculty of Chemical Technology, University of Pardubice. Final report on testing the antimicrobial activity of the product OKCEL®. Data on file: 18640 - 034.